DAVID O'CONNOR: Open Payments
NPI 1699798595 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 12 payments from 7 companies in 2025. Trend: 2023 $433 · 2024 $927 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| ABBVIE INC. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Vertical Pharmaceuticals, LLC | 2 | $29 |
| Corium, LLC | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: UZEDY, VRAYLAR, REXULTI, Relexxii, Azstarys, INVEGA SUSTENNA, AUSTEDO XR, Qelbree.
Industry payments across TX — which companies pay providers there.
